Item
Guggulipid Extract (2.5% Z+E G (0742)
GUGULIPID 2.5% GRANULES from Commiphora mukul Gum exudates is Intended for Nutraceutical application.
For more details refer specification & www.sabinsa.com
Botanicals
Locations
| Location name | Address |
|---|---|
| SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | 20 LAKE DR 20 lake drive EAST WINDSOR, NJ 08520-5321 |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Allergens | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Allergens.pdf | 2/14/2020 | 2/13/2022 |
| Country of Origin | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Country of Origin.pdf | 2/14/2020 | 2/13/2023 |
| GMO | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | GMO free statement.pdf | 2/27/2020 | 2/26/2022 |
| Residual Statement | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Gugulipid granules 25 - Issue 5.pdf | 2/14/2020 | 2/13/2021 |
| Shelf Life | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Gugulipid granules 25 - Issue 5.pdf | 2/14/2020 | 2/13/2023 |
| California Prop. 65 | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Prop 65 Declaration.pdf | 2/27/2020 | 2/26/2022 |
| BSE - TSE | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | TSE BSE Declaration.pdf | 2/27/2020 | 2/26/2023 |
| WADA/NSF/NFL Statement | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | WADA Declaration.pdf | 2/27/2020 | 2/26/2022 |
